Siawosh K Eskandari

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Extracorporeal Membrane Oxygenation

Chronic Lymphocytic Leukemia

Top Venues

The New England journal of medicine

Transplant infectious disease : an official journal of the Transplantation Society

Science translational medicine

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

This page only lists publications with an associated author ORCID identifier.

Publications

Siawosh K Eskandari, Elisabeth G M Revenich, Dirk J Pot, Foekje de Boer, Marc Bierings, Francjan J van Spronsen, Peter M van Hasselt, Caroline A Lindemans, Charlotte M A Lubout
High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman's Disease. The New England journal of medicine 390 (7) (2024)
Siawosh K Eskandari, Elisabeth G M Revenich, Dirk J Pot, Foekje de Boer, Marc Bierings, Francjan J van Spronsen, Peter M van Hasselt, Caroline A Lindemans, Charlotte M A Lubout
High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman's Disease. The New England journal of medicine 390 (7) (2024)
Siawosh K Eskandari, Mariana Gaya da Costa, Bernardo Faria, Vojtech Petr, Jamil R Azzi, Stefan P Berger, Marc A J Seelen, Jeffrey Damman, Felix Poppelaars
An interleukin 6-based genetic risk score strengthened with interleukin 10 polymorphisms associated with long-term kidney allograft outcomes. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2022)
Siawosh K Eskandari, Sterre Y Jonkers, Mohammad A M Almesned, Onno W Akkerman, Erik Alfons Maria Verschuuren, Christiaan Tji-Joong Gan
Recurrent fever 3 years post-lung transplantation: A treacherous case of Mycobacterium genavense. Transplant infectious disease : an official journal of the Transplantation Society (2021)
Siawosh K Eskandari, Ina Sulkaj, Mariane B Melo, Na Li, Hazim Allos, Juliano B Alhaddad, Branislav Kollar, Thiago J Borges, Arach S Eskandari, Max A Zinter, Songjie Cai, Jean Pierre Assaker, John Y Choi, Basmah S Al Dulaijan, Amr Mansouri, Yousef Haik, Bakhos A Tannous, Willem J van Son, Hendrik Gerrit Derk Leuvenink, Bohdan Pomahac, Leonardo V Riella, Li Tang, Marc A J Seelen, Darrell J Irvine, Jamil R Azzi
Regulatory T cells engineered with TCR signaling-responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter. Science translational medicine 12 (569) (2021)